Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors

Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion in Gross Value Added (GVA) to the Australian economy in 2019. Its future is dependent on the skills of its workforce.
Earlier this year, MTPConnect set out to better understand the sector’s workforce needs and skills gaps by funding some sector research.
Working with the support of a cross-industry project team of AusBiotech, ANDHealth, Medical Technology Association of Australia (MTAA) and Medicines Australia, an online survey of human resource (HR) professionals and managers with hiring responsibilities in the sector was developed to find out more.
The results of the survey are in and BehaviourWorks Australia, a research enterprise within the Monash Sustainable Development Institute has prepared the following report, ‘A Survey of Workforce Skills and Capacity in the Medical Technology, Biotechnology, Pharmaceutical and Digital Health (MTP) Sector’.
This report identifies current, emerging and future skills gaps that need to be addressed in order to drive employment and growth in the Australian MTP sector, including:
- Business skills and commercial expertise
- Regulation and quality
- Clinical (including trials)
- Biological sciences and technologies
- Informatics, computation, mathematical and statistics and;
- Chemical science
Feedback concerning the lack of real-world experience in industry shows there is more work to be done to support career development opportunities in our sector.
These survey results have now been incorporated into a comprehensive Skills Gap Analysis being undertaken by L.E.K for MTPConnect’s REDI program.
REDI is a four-year $32 million MRFF funded program which aims to build the MTP workforce, address skills gaps and enhance entrepreneurship in Australia. An interim Skills Gap Analysis report will be released next month.
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More